CVS HEALTH CORPORATION Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
CVS HEALTH CORPORATION (CVS) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $50.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2026-02-10
- CVS HEALTH CORPORATION effective income tax rate reconciliation, tax credit, research, amount for fiscal 2025 was $50.00M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month |
|---|---|
| 2025-12-31 | $50.00M 10-K · filed 2026-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |